Abbott and Cardiovascular Systems, Inc. announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.

Grifols Diagnostic Solutions announced Thursday its Procelix Panther System featuring Automation Ready Technology (ART) received approval from the US Food and Drug Administration.

A new study by Veracyte and collaborators demonstrates that the companys Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease. The study, published this week in Lancet Respiratory Medicine